The START Center for Cancer Care.
San Antonio, Texas, United States
Cancer treatment center in San Antonio, Texas
4383 Medical Dr, San Antonio, TX 78229
About The START Center for Cancer Care.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Ascentage Pharma Group Inc.
3
Compugen Ltd
3
Gilead Sciences
2
Incyte Corporation
2
Novartis Pharmaceuticals
2
Syndax Pharmaceuticals
2
Translational Oncology Research International
2
Treadwell Therapeutics, Inc
2
23andMe, Inc.
1
ADC Therapeutics S.A.
1
Clinical Trials at The START Center for Cancer Care.
During the past decade, The START Center for Cancer Care. conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 7 clinical trials were completed, i.e. on
average, 18.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 4 clinical trials were completed. i.e. 23.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
2006-01-01
2010-06-01
Completed
23
First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
2007-01-01
2008-01-01
Completed
34
A Phase I, Open-label, Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Endothelin B Agonist, SPI-1620, in Patients With Recurrent or Progressive Carcinoma
2008-01-01
2012-12-01
Completed
36
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
2009-03-01
2013-04-09
Completed
861
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
2010-02-01
2019-12-01
Completed
3,000
Multi-Institutional Registry for Prostate Cancer Radiosurgery
2010-07-01
2020-07-01
Unknown status
3,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The START Center for Cancer Care." #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Ascentage Pharma Group Inc." with 3 trials
sponsored, "Compugen Ltd" with 3 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Incyte Corporation"
with 2 trials sponsored. Other sponsors include 30 different institutions and
companies that sponsored additional 36 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The START Center for Cancer Care."
#1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator and "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at The START Center for Cancer Care.
According to Clinical.Site data, the most researched conditions in "The START Center for Cancer Care." are
"Solid Tumor" (10 trials), "Advanced Solid Tumor" (6 trials), "Ovarian Cancer" (5 trials), "Breast Cancer" (4 trials) and "Neoplasms" (4 trials). Many other conditions were trialed in "The START Center for Cancer Care." in a lesser frequency.
Clinical Trials Intervention Types at The START Center for Cancer Care.
Most popular intervention types in "The START Center for Cancer Care." are "Drug" (46 trials), "Biological" (3 trials), "Combination Product" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Pembrolizumab" (7 trials), "Gemcitabine" (5 trials), "Cetuximab" (2 trials), "Docetaxel" (2 trials) and "Entinostat" (2 trials). Other intervention names were less common.
Clinical Trials Genders at The START Center for Cancer Care.
The vast majority of trials in "The START Center for Cancer Care." are
42 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at The START Center for Cancer Care.
Currently, there are NaN active trials in "The START Center for Cancer Care.".
undefined are not yet recruiting,
15 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in The START Center for Cancer Care.,
1 suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in The START Center for Cancer Care., 37 "Phase 1"
clinical trials were conducted, 18 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".